These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30159853)

  • 21. Optic neuropathy in methylmalonic acidemia and propionic acidemia.
    Martinez Alvarez L; Jameson E; Parry NR; Lloyd C; Ashworth JL
    Br J Ophthalmol; 2016 Jan; 100(1):98-104. PubMed ID: 26209586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
    Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
    Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.
    Kölker S; Valayannopoulos V; Burlina AB; Sykut-Cegielska J; Wijburg FA; Teles EL; Zeman J; Dionisi-Vici C; Barić I; Karall D; Arnoux JB; Avram P; Baumgartner MR; Blasco-Alonso J; Boy SP; Rasmussen MB; Burgard P; Chabrol B; Chakrapani A; Chapman K; Cortès I Saladelafont E; Couce ML; de Meirleir L; Dobbelaere D; Furlan F; Gleich F; González MJ; Gradowska W; Grünewald S; Honzik T; Hörster F; Ioannou H; Jalan A; Häberle J; Haege G; Langereis E; de Lonlay P; Martinelli D; Matsumoto S; Mühlhausen C; Murphy E; de Baulny HO; Ortez C; Pedrón CC; Pintos-Morell G; Pena-Quintana L; Ramadža DP; Rodrigues E; Scholl-Bürgi S; Sokal E; Summar ML; Thompson N; Vara R; Pinera IV; Walter JH; Williams M; Lund AM; Garcia-Cazorla A
    J Inherit Metab Dis; 2015 Nov; 38(6):1059-74. PubMed ID: 25875216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The markers of the organic acidemias and their ratios in healthy neonates in Serbian population.
    Beletić A; Tijanić A; Chrastina P; Nikolić T; Stefanović A; Stanković S
    Drug Metab Pers Ther; 2022 Sep; 37(3):271-275. PubMed ID: 35254746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial.
    Alfadhel M; Nashabat M; Saleh M; Elamin M; Alfares A; Al Othaim A; Umair M; Ahmed H; Ababneh F; Al Mutairi F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Almannai M; Aljeraisy M; Albdah B; Hussein MA; Rahbeeni Z; Alasmari A
    Orphanet J Rare Dis; 2021 Oct; 16(1):422. PubMed ID: 34635114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
    Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
    Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver and/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: An overview on European data.
    Molema F; Martinelli D; Hörster F; Kölker S; Tangeraas T; de Koning B; Dionisi-Vici C; Williams M;
    J Inherit Metab Dis; 2021 May; 44(3):593-605. PubMed ID: 32996606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
    Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
    Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship between Dietary Intake, Growth, and Body Composition in Inborn Errors of Intermediary Protein Metabolism.
    Evans M; Truby H; Boneh A
    J Pediatr; 2017 Sep; 188():163-172. PubMed ID: 28629683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
    Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
    BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study.
    Yap S; Lamireau D; Feillet F; Ruiz Gomez A; Davison J; Tangeraas T; Giordano V
    Drugs R D; 2024 Mar; 24(1):69-80. PubMed ID: 38198106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical variability of isovaleric acidemia in a genetically homogeneous population.
    Dercksen M; Duran M; Ijlst L; Mienie LJ; Reinecke CJ; Ruiter JP; Waterham HR; Wanders RJ
    J Inherit Metab Dis; 2012 Nov; 35(6):1021-9. PubMed ID: 22350545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylmalonic and propionic acidemias: clinical management update.
    Fraser JL; Venditti CP
    Curr Opin Pediatr; 2016 Dec; 28(6):682-693. PubMed ID: 27653704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of tandem mass spectrometry in diagnosis of organic acidemias].
    Han LS; Gao XL; Ye J; Qiu WJ; Gu XF
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):325-30. PubMed ID: 15924743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).
    Sikirica V; Schwartz EJ; Vockley J; Stagni K; Bellenger MA; Banerjee G; Durgam N; Moshkovich O
    Mol Genet Metab; 2024; 143(1-2):108577. PubMed ID: 39303317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the pathophysiology of methylmalonic acidemia.
    Head PE; Meier JL; Venditti CP
    J Inherit Metab Dis; 2023 May; 46(3):436-449. PubMed ID: 37078237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn screening and disease variants predict neurological outcome in isovaleric aciduria.
    Mütze U; Henze L; Gleich F; Lindner M; Grünert SC; Spiekerkoetter U; Santer R; Blessing H; Thimm E; Ensenauer R; Weigel J; Beblo S; Arélin M; Hennermann JB; Marquardt T; Marquardt I; Freisinger P; Krämer J; Dieckmann A; Weinhold N; Keller M; Walter M; Schiergens KA; Maier EM; Hoffmann GF; Garbade SF; Kölker S
    J Inherit Metab Dis; 2021 Jul; 44(4):857-870. PubMed ID: 33496032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.